LNB
JAZZ icon

Ledyard National Bank’s Jazz Pharmaceuticals JAZZ Stock Holding History

Ledyard National Bank’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-75
Closed -$9K – 468
2018
Q4 		$9K Hold
75
– – ﹤0.01% 616
2018
Q3 		$13K Hold
75
– – ﹤0.01% 576
2018
Q2 		$13K Hold
75
– – ﹤0.01% 588
2018
Q1 		$11K Sell
75
-34
-31% -$4.99K ﹤0.01% 630
2017
Q4 		$15K Buy
109
+34
+45% +$4.72K ﹤0.01% 607
2017
Q3 		$11K Hold
75
– – ﹤0.01% 643
2017
Q2 		$12K Hold
75
– – ﹤0.01% 589
2017
Q1 		$11K Hold
75
– – ﹤0.01% 602
2016
Q4 		$8K Buy
+75
New +$8.35K ﹤0.01% 515

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Ledyard National Bank's JAZZ Position: Q1 2019 in Review

Ledyard National Bank sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2019, closing a stake of 75 shares — an estimated $9K sold.

Ledyard National Bank first reported a position in JAZZ in Q4 2016 and held it in 9 quarters. The position peaked at $15K in Q4 2017. 427 funds tracked by Wall St. Rank hold JAZZ as of Q1 2019.

  • Ledyard National Bank reported no remaining Jazz Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Ledyard National Bank sold 75 Jazz Pharmaceuticals shares in Q1 2019, an estimated $9K.
  • Ledyard National Bank first reported a position in Jazz Pharmaceuticals in Q4 2016 and held it in 9 quarters.
  • Ledyard National Bank's Jazz Pharmaceuticals position peaked at $15K in Q4 2017.
  • 427 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2019.

Based on Ledyard National Bank's 13F filing for Q1 2019, filed 12 Apr 2019.